Cabozantinib-S-malate API

Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of cabozantinib-s-malate api in China. We warmly welcome yuo to wholesale bulk cabozantinib-s-malate api for sale here from our factory. Quality products and reasonable price are available.

What Is Cabozantinib-s-Malate

Cabozantinib-S-malate API is classified as a tyrosine kinase inhibitor (TKI). It is primarily used in the treatment of various types of cancers, notably advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). The drug works by inhibiting multiple targets involved in tumor growth and cancer progression, including the vascular endothelial growth factor receptors and the MET receptor tyrosine kinase, which play crucial roles in angiogenesis and tumor cell proliferation. XL184 is marketed under the brand name Cometriq for medullary thyroid cancer and as Cabometyx for renal cell carcinoma and hepatocellular carcinoma. Its multi-target approach makes it effective against a range of malignancies, contributing to its therapeutic applications in oncology.

Certificate Of Analysis

Where To Buy Cabozantinib-s-Malate

Xi'an Sonwu Biotech Co. Ltd. has rich experience in the global trade and health industry. Insisting on faith-based and quality first is our company's principle. We strictly control product quality, which means selection starts from raw materials. Besides, we handle every detail and reduce the cost to the maximum extent, then our customers can get cost-effective products. Based on these, customers have given much good feedback to our products. So you can look for Xi'an Sonwu Biotech Co. Ltd. when you want to buy Cabozantinib-s-Malate Powder.

Xi'an Sonwu completely makes sure of the product's quality, so samples can be supplied. Here is the quantity.

Customers' Good Comment

What Is The Mechanism Of Action Of Cabozantinib

This small chemical tyrosine kinase inhibitor targets several pathways that contribute to the development and spread of tumors. Its mechanism of action can be summarized through several key points:

1. Targeting Tyrosine Kinases: XL184 primarily inhibits signaling through two main pathways:

- VEGFR (Vascular Endothelial Growth Factor Receptor): By inhibiting VEGFR1, VEGFR2, and VEGFR3, XL184 disrupts angiogenesis-the development of new blood vessels, which are necessary for tumor growth and metastasis.

- MET (Hepatocyte Growth Factor Receptor): It also inhibits the MET receptor, which is involved in cell proliferation, survival, and motility. MET signaling can promote tumor cell invasion and metastasis, and its inhibition can have effects on tumor growth.

2. Other Targets: In addition to VEGFR and MET, XL184 also targets several other receptor tyrosine kinases (RTKs), including AXL, RET, and ROS1. This broad activity against multiple kinases contributes to its efficacy in treating various cancers.

3. Effects on Tumor Microenvironment: The inhibition of these pathways not only affects the tumor cells directly but also alters the tumor microenvironment. By inhibiting angiogenesis and cell signaling pathways that promote metastasis, XL184 can affect tumor cell behavior and improve immune system response against tumor cells.

4. Clinical Use: It is approved for use in different types of cancers, including advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). Its indication for different cancers is largely due to its role in inhibiting multiple pathways that are activated in these malignancies.

All things considered, cabozantinib's usefulness in cancer treatment comes from its capacity to block several pathways that promote tumor development, angiogenesis, and metastasis.

What Is Cabozantinib Used For

Cabozantinib-S-malate powder is primarily used in the treatment of several types of cancer. Specifically, it is indicated for the following conditions:

1. Medullary Thyroid Cancer

- It is approved for the treatment of patients with medullary thyroid carcinoma (MTC) that is progressive (i.e., worsening or spreading) and for which surgery is not an option.

2. Renal Cell Carcinoma (RCC)

- It can be used to treat advanced renal cell cancer, particularly in patients who have received prior therapy. This includes both clear cell and non-clear cell subtypes of RCC.

3. Hepatocellular Carcinoma (HCC)

- It is used for patients with hepatocellular carcinoma who have previously been treated with a systemic therapy. It is effective in managing advanced liver cancer.

4. Other Potential Uses

- While these are the primary indications, research is ongoing to explore the efficacy of cabozantinib in other malignancies, and it may be studied in combination with other therapies for various cancers, including those that involve MET or VEGF pathway dysregulation.

Cabozantinib S-Malate Side Effects

XL184 can cause a range of side effects. Below are the common and serious side effects associated with its use:

1. Fatigue: A common issue experienced by many patients.

2. Diarrhea: Frequent loose stools are commonly reported.

3. Nausea and Vomiting: Gastrointestinal symptoms can occur.

4. Decreased Appetite: Some patients may experience a loss of appetite.

5. Weight Loss: Often related to decreased appetite and gastrointestinal side effects.

6. Abdominal Pain: Discomfort or pain in the abdominal area.

7. Mouth Sores: Oral mucositis or ulcers can occur.

8. Hypertension: Increased blood pressure is a notable side effect.

• Monitoring and Management

- Regular Monitoring: Patients receiving XL184 should be monitored regularly for liver function tests, blood pressure, renal function, and signs of gastrointestinal bleeding.

- Managing Side Effects: Many side effects can be managed with supportive care, including hydration, anti-nausea medications, and adjustments to diet and activity levels.

While Cabozantinib-S-malate API can be effective in treating certain cancers, it is associated with a variety of side effects that require careful monitoring and management. Patients should be informed about potential side effects and should report any unusual or severe symptoms to their healthcare provider promptly. Always follow your healthcare provider's recommendations regarding monitoring and management of side effects while on this medication.

How Do You Take Cabozantinib

XL184 is typically taken orally in the form of a tablet. Here are the general guidelines for taking it:

• Dosage and Administration

Formulation: XL184 is available as a tablet and is usually prescribed in specific doses depending on the type of cancer being treated.

Dosage: The typical starting dose is often 60 mg once daily, but this can change according to specific indications and individual patient factors. Always follow the dosing prescribed by your healthcare provider.

• Timing:

Take XL184 once a day at the same time to maintain stable hormone levels in the body.

It can be taken with or without food, but consistency in relation to meals is important (i.e., always take it either with food or on an empty stomach).

• Missed Dose:

If you miss a dose, take it as soon as you remember on the same day. However, if it is almost time for your next dose, you do not need to take the missed dose. Do not take two doses at the same time to make up for a missed dose.

Hydration: It's important to stay well-hydrated while taking XL184.

• Monitoring

Regular Checkups: Regular monitoring by your healthcare provider is essential while on XL184. This could involve liver function testing with blood tests, kidney function, and electrolytes, among other things.

Report Side Effects: Consult with your healthcare provider if you experience significant side effects, such as severe diarrhea, symptoms of liver dysfunction (such as jaundice), or any other concerning symptoms.

It is important to follow advice of your healthcare expert about your cabozantinib prescription, including dosage, timing, and any dietary restrictions. Adherence to your treatment plan, as well as consistent dialogue with your medical team, is crucial for the effectiveness of the therapy and your overall health.

How Long Can You Take Cabozantinib

The duration of treatment with XL184 can change widely depending on a number of factors, including the type of cancer being treated, the patient's response to treatment, and whether side effects occur. The following are important factors to think about when determining how long this treatment will last:

1. Cancer Type: It is used to treat various cancers, including advanced renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC). The treatment regimen may differ based on the specific indications and the clinical setting.

2. Treatment Response: Patients are typically monitored for their response to XL184 through imaging studies and other assessments. If a patient shows a positive response-like tumor shrinkage or stabilization-the treatment may be continued.

3. Side Effects: The management of side effects is crucial in determining the length of treatment. If a patient experiences severe adverse effects, the oncologist may assess the risks and benefits of continuing therapy and may decide to pause or adjust the dosage.

4. Clinical Guidelines: Treatment duration is often guided by clinical protocols and the expertise of the healthcare provider. Some treatment guidelines may suggest continuing XL184 until disease progression or unacceptable toxicity occurs.

5. Ongoing Monitoring: Typically, patients receive routine follow-up care to evaluate how well they respond to treatment and track any side effects. The oncologist may recommend periodic imaging and lab tests to make informed decisions on continuing or stopping the medication.

Ultimately, the decision on how long to take XL184 should be made collaboratively between the patient and their healthcare team, based on individual circumstances and clinical judgment. If you have specific questions about treatment duration, it is best to discuss them directly with your oncologist.

Factory

1. Xi'an Sonwu has a factory with sufficient stock. In addition, Xi'an Sonwu has a clean and tidy production department with advanced equipment. Under the company's leadership, researchers continue to develop new products to meet customers' needs.

2. Xi'an Sonwu has advanced testing equipment and professional testing personnel, all of which show that Xi'an Sonwu aims to provide accurate and effective data and good service.

Certificate

Package

Logistics Update

In addition to guaranteeing product quality, the other most vital thing is clients could receive the goods smoothly. So, Xi'an Sonwu supplies all kinds of couriers according to different needs.

Company's Profile

Xi'an Sonwu Biotech Co., Ltd is a professional Chinese manufacturer and products supplier. It was founded in 2012 and is located in the Hi-Tech Industrial Zone, Xi'an City, Shannxi Province, China. It pays all attention to the development, research, and production of food additives, plants, extract, APl, and other ingredients of health care products. The company supplies five kinds of raw material products: Anti-hair loss Powders, Nootropic, API, Muscle Building products, and Plant Extract. Xi'an Sonwu sincerely believes that the premise of great cooperation is the best service and good quality. So, welcome your inquiry when you want Cabozantinib-s-Malate Powder.

And if you want to know the Cabozantinib-S-malate API price, please contact XI'an Sonwu.

Email: sales@sonwu.com

Hot Tags: cabozantinib-s-malate api, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, 4 Aminobenzamidine Dihydrochloride, Salcaprozate Sodium Powder, Ulinastatin Powder, Fulvestrant Powder, API, NAD Nicotinamide Adenine Dinucleotide